cancer

articles with this tag

Could a Loxo Oncology Style Trial, Bring Loxo Style Results for PTX?

Could a Loxo Oncology Style Trial, Bring Loxo Style Results for PTX?

Clinical stage oncology company, Prescient Therapeutics (ASX:PTX) is in a fortunate position. It has two clinical candidates, four trials, and multiple possible pathways to market for its targeted therapies that address specific mutations that drive cancer and contribute to resistance.

READ ARTICLE

ASX Biotech Eyes International Distribution of Overlooked Cancer Drug

ASX Biotech Eyes International Distribution of Overlooked Cancer Drug

Today’s biotech junior is in the business of repurposing late-stage drug assets that have been overlooked by big pharma.

READ ARTICLE